OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and more than 40 countries outside the United States.
Investors
Change (%)
Volume
Data as of
Data Provided by Refinitiv. Minimum 15 minutes delayed.
WARSAW, Ind. , March 31, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey , President, Fred Hite , Chief Operating Officer and Chief
The Internal Brace Option™ is a viable alternative for treating progressive moderate scoliosis in adolescents and a game-changing treatment option for medical providers and patients to consider WARSAW, Ind. , March 23, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp.
Full year 2020 revenue of $71.1m compared to full year 2019 revenue of $72.6m , reflecting the impact of COVID-19 on elective surgeries Guidance for full year 2021 sales growth in the range of 31-38%, reaching $93-98 million WARSAW, Ind. , March 10, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp.
